From Diagnosis to Therapy—PET Imaging for Pheochromocytomas and Paragangliomas

Hiren V. Patel, Arnav Srivastava, Murray D. Becker, Toni Beninato, Amanda M. Laird, Eric A. Singer

    Research output: Contribution to journalReview articlepeer-review

    2 Scopus citations


    Purpose of Review: Pheochromocytoma and paraganglioma (PPGLs) are neuroendocrine tumors with diverse clinical presentations. PPGLs can be sporadic but often are associated with various syndromes, which can have variable clinical presentations. A thorough workup is therefore critical for staging, treatment, and follow-up. Imaging is an essential part of the workup and diagnosis of PPGLs. Recent Findings: Improvements in cross-sectional imaging with radionuclides have increased specificity and sensitivity for identifying and treating PPGLs. Furthermore, a variety of targets on PPGLs has allowed for optimal imaging with radionuclides that can be used for staging and treatment. Currently, radionuclides are being evaluated for staging and treatment of PPGLs. Summary: Developing novel radionuclides that can identify disease sites and target them simultaneously provides a potential for improving survival and outcomes in patients with PPGLs. Given the clinical diversity among PPGLs, expanding the therapeutic arsenal against locally advanced or metastatic PPGLs can allow clinicians to evaluate and treat PPGLs thoroughly.

    Original languageEnglish (US)
    Article number2
    JournalCurrent urology reports
    Issue number1
    StatePublished - Jan 2021

    All Science Journal Classification (ASJC) codes

    • Urology


    • PET imaging
    • Paragangliomas
    • Pheochromocytomas
    • Radiotracers


    Dive into the research topics of 'From Diagnosis to Therapy—PET Imaging for Pheochromocytomas and Paragangliomas'. Together they form a unique fingerprint.

    Cite this